Evolving Well, LLC – Trademark Portfolio
Entity Type: 16
Evolving Well, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include DERMA QUELL, NUTRA QUELL, and SKIN RASH REBUILD. The owner is based in Bridgeport, PA.
25 West 6th Street
Bridgeport, PA 19405
Showing of trademarks Trademarks
Trademark Classifications
Evolving Well, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Evolving Well, LLC have?
Evolving Well, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does Evolving Well, LLC file in?
Evolving Well, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Evolving Well, LLC's most well-known trademarks?
Evolving Well, LLC's registered trademark portfolio includes well-known marks such as DERMA QUELL, NUTRA QUELL, and SKIN RASH REBUILD. These are among 3 currently registered trademarks in the portfolio.
What is Evolving Well, LLC's trademark registration success rate?
Evolving Well, LLC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.